Mauritius-based Eriska Investment Fund Limited has picked up 50,000 (Fifty Thousand) equity shares in Sampre Nutritions Ltd on Thursday. Eriska Investment Fund bought the stake in the  Gurbani Group company at an average price of Rs 101 apiece, amounting to Rs 50.5 lakh, as per an official statement. 

COMMERCIAL BREAK
SCROLL TO CONTINUE READING

The BSE Listed company, which has a manufacturing facility in Hyderabad, is engaged in manufacturing confectionery chocolates, hard boiled candies and other products. It has a complete equity research and development (R&D) facility for the aforementioned products.

Sampra Nutrition is the only Indian company approved by Procter and Gamble (P&G) to export Vicks Cough Drops in Japan.

BK Gurbani is currently Chairman of the Group having vast experience in FMCG industries, confectionery and allied fields. He is also the President of Indian Confectionery Manufacturer's Association (ICMA).

"In association with Micro Nutrient Initiatives Canada, Sampre has developed vitaminized candy nutri candy which had proven therapeutic of improving the hemoglobin levels after complete studies effectiveness and efficacies done by AIIMS Institute, Delhi for malnourished children and lactating mothers. This product was made available through Aaganwadi in various states in the country," an official statement said.

The company says it has been associated with leading brands for their flagship products including 'Vicks' for Procter & Gamble. 'Hajmola' for Dabur, 'Rapid Relief' for Cipal, 'Eclairs' for Cadbury and 'Frutus' for Nestle.